Show Summary Details
Page of

Epidemiology and healthcare burden of fibromyalgia syndrome 

Epidemiology and healthcare burden of fibromyalgia syndrome
Chapter:
Epidemiology and healthcare burden of fibromyalgia syndrome
Author(s):

Ernest Choy

DOI:
10.1093/med/9780198723233.003.0002
Page of

PRINTED FROM OXFORD MEDICINE ONLINE (www.oxfordmedicine.com). © Oxford University Press, 2016. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 21 July 2019

Fibromyalgia syndrome is very common. Prevalence in the general population is approximately 2% based on the American College of Rheumatology 1990 criteria, and 5–6% based on the American College of Rheumatology 2010 preliminary criteria. It is commoner in women than in men, with a gender ratio of 7:1 based on the American College of Rheumatology 1990 criteria and 3:1 based on the American College of Rheumatology 2010 preliminary criteria. Differences in prevalence and gender ratio between American College of Rheumatology 1990 and 2010 criteria are mainly due to the threshold (11/18) for tender point count being less likely to be met in men. Physical function and quality of life are significantly reduced in fibromyalgia syndrome. Most patients have chronic disease. Spontaneous remission is uncommon. Medical cost is high, up to 10 years prior to diagnosis. Societal cost of fibromyalgia syndrome due to reduced productivity is also high. Constructive diagnosis can reduce healthcare cost.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.